OptiBiotix grabbed its ten-bagger status within a year of joining AIM. Since then it has come off the boil a little. That's probably partly due to the fact that the mad enthusiasm for the UK's biotech market has died down a little and partly because Opti's boss Stephen O'Hara is very careful not to overpromise. Still, he is very popular with his retail shareholders and has big plans for growing his company (albeit carefully).
For access to the top news and insights from the investment worldREGISTER FREE TODAY